SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

With no major difference for the quarter endedSeptember 2023 , the total revenue stood at Rs. 2600.00  millions.The Net Loss for the quarter ended September 2023 is Rs. -1070.00 millions as compared to Net Loss of Rs. -750.00 millions of corresponding quarter ended September 2022Operating profit Margin for the quarter ended September 2023 slipped to -40.00% as compared to 400.00% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 2600.00 2580.00 0.78 5110.00 4990.00 2.40 10720.00 13720.00 -21.87
Other Income 60.00 290.00 -79.31 120.00 780.00 -84.62 670.00 380.00 76.32
PBIDT -40.00 400.00 -110.00 -30.00 940.00 -103.19 1370.00 2600.00 -47.31
Interest 590.00 580.00 1.72 1170.00 1190.00 -1.68 2290.00 2730.00 -16.12
PBDT -630.00 -680.00 -7.35 -1340.00 -750.00 78.67 -3270.00 -130.00 2415.38
Depreciation 440.00 470.00 -6.38 880.00 940.00 -6.38 1860.00 1710.00 8.77
PBT -1070.00 -1150.00 -6.96 -2220.00 -1690.00 31.36 -5130.00 -1840.00 178.80
TAX 0.00 -400.00 0.00 0.00 -570.00 0.00 -470.00 -440.00 6.82
Deferred Tax 0.00 -400.00 0.00 0.00 -570.00 0.00 -470.00 -490.00 -4.08
PAT -1070.00 -750.00 42.67 -2220.00 -1120.00 98.21 -4660.00 -1400.00 232.86
Equity 720.00 720.00 0.00 720.00 720.00 0.00 720.00 720.00 0.00
PBIDTM(%) -1.54 15.50 -109.92 -0.59 18.84 -103.12 12.78 18.95 -32.56

Wockhardt Share Price

1396.80 37.70 (2.77%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×